RecruitingNot ApplicableNCT03787589

Exercise in Patients With End Stage Kidney Disease

A Simple Exercise Program for Patients With End Stage Kidney Disease to Improve Strength and Quality of Life: A Feasibility Study

Sponsor

Ottawa Hospital Research Institute

Enrollment

90 participants

Start Date

Apr 15, 2019

Study Type

INTERVENTIONAL

Conditions

Renal Failure

Summary

This study will be conducted over a 3 year time period. This is a trial of an exercise intervention vs. standard of care in patients receiving chronic dialysis. The specific aims will be to determine feasibility of patient recruitment, adherence to the exercise program, and efficacy of the intervention on patient important outcomes. The exercise intervention will be delivered to randomized participants for 12 months, and consist of the prescribed use of Nordic Walking poles, online resources for exercise in the home, regular use of a pedometer to monitor progress, and regular verbal encouragement to exercise (monthly) by dialysis unit staff. Both groups will receive the same standard of care co-interventions including individualized dialysis prescriptions and health-care interactions according to practices at their centre.

Eligibility

Min Age: 18 Years

Inclusion Criteria5

All ambulatory adult patients with end stage kidney disease
Treatment with peritoneal dialysis or hemodialysis for greater than six months
Able to understand English or French
Abuse to use Nordic Walking poles
Able and willing to provide informed consent

Exclusion Criteria6

Any absolute contraindication to exercise \[unstable angina, uncontrolled hypertension (systolic or diastolic blood pressure greater than 180 mmHg (millimeters of mercury) or greater than 110 mmHg, respectively), deemed not suitable for exercise by the treating physician\]
Baseline step count greater than 8000 steps a day
Planned living donor kidney transplant
Potential for recovery of renal function
Patients who feel unsafe using Nordic walking poles in place of their mobility aid
Participation in another interventional trial that may affect the results of this study

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

BEHAVIORALExercise Prescription

Participants in the intervention group will be given an exercise prescription to increase their baseline steps by 1200 and 2000 steps per day at least 3 days a week over the first 3 months. If tolerated and accepted, the participants will increase their step counts by an additional 600 to 1000 steps per day at least 3 days a week for the next 3 months.This will be followed by a 6-month maintenance phase. The research coordinator will instruct the participants on the proper use of the Nordic walking poles which can be used to help participants achieve their prescribed number of steps. All participants will be encouraged to wear the pedometer throughout the trial in order to follow the step-count prescription and monitor adherence.